By Michele Maatouk
Date: Monday 03 Aug 2026
(Sharecast News) - AstraZeneca is reportedly in talks to combine with US rival Bristol Myers Squibb in a deal that would create one of the world's biggest pharmaceutical groups, valued at nearly $400bn.
| Currency | US Dollars |
| Share Price | $ 64.10 |
| Change Today | $ 0.46 |
| % Change | 0.72 % |
| 52 Week High | $68.09 |
| 52 Week Low | $42.60 |
| Volume | 6,903,983 |
| Shares Issued | 2,013.00m |
| Market Cap | $129,033m |
| RiskGrade | 106 |
| Time | Volume / Share Price |
| 16:00 | 1,490,808 @ $64.10 |
| 15:59 | 100 @ $64.10 |
| 15:59 | 100 @ $64.10 |
| 15:59 | 100 @ $64.10 |
| 15:59 | 100 @ $64.10 |
You are here: research